Back to All

Capital Markets Day 2021 Presentation

23 June, 2021

Diaceutics PLC 

("Diaceutics" or "the Group")

Capital Markets Day

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, hosted a virtual Capital Markets Day ("CMD") for investors and equity analysts on Wednesday 16th June 2021.

The event was hosted by Group CEO, Peter Keeling, and included a series of presentations, a demonstration of the DXRX SaaS platform, and views from an industry expert panel including:

  • Pharmaceutical Partner: a senior executive within one of the world’s top five pharmaceutical companies
  • Laboratory Partner: Professor Giancarlo Pruneri, Head of Pathology Fondazione IRCCS Istituto Nazionale Tumori, Milan
  • Key Opinion Leader: Dr Avi Kulkarni, SVP and R&D leader at Nasdaq listed technology firm Cognizant

In addition, a strategic update was heard from the Company, along with a live Q&A.

If you are interested in the contents or have any questions relating to the Diaceutics Capital Markets Day please contact [email protected]


Diaceutics PLC

Peter Keeling, Chief Executive Officer

Philip White, Chief Financial Officer

via Alma PR

Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)

Ben Maddison

Stewart Wallace

Nick Adams

+44 (0)20 7710 7600

Alma PR

Caroline Forde

Robyn Fisher

Kieran Breheny

Tel: +44 (0)20 3405 0205

[email protected]

About Diaceutics

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.

DXRX is the world’s first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Diaceutics PLC

Philip White
Chief Financial Officer
+44 (0) 7801 611 921

Nominated adviser and broker

Stifel Nicolaus Europe Limited
150 Cheapside

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny